# AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-28 18:29 UTC · Category: Business · Sources: 6 · Current Velocity: 3.67

## Key People, Organizations & Locations
FDA, Parkinson, AbbVie, Cerevel, Juvmo

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| WGN-TV | FDA approves Juvmo, a first-of-its-kind medication for Parkinson’s disease | 2026-09-28 12:15 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxPV0E3S2pCUUc0QVI2YWNXcTR0Q19pTk5iRWFaMklCZlNMcnhxeGdUVXk3eGV2VWQzdjlKVnFMNmVpZEktRzZVNERfLTByNGxORnBkbkFOMGpWbTVSTHJ2ZWRxY3RkMmYza1JrNy1raVUyVGd2R08zbG1SVzBxczN1QXdxYXJlZU5yX0hWZHA0aGd6c0VJUXF3S21LQ21zcUdSd0hFeFhkZ242VE5KdVMw0gG0AUFVX3lxTE9UUTVGRTd4ekRJaWp4RHpmM01UTXQ1cVk3dHVQdlhDenJobDZvUjVBTzkyMWIxLThXU0w3RGt1OHFfRWJyWTdLOEpXRm5BdndlT0M1alY4cHVjeUhYbV9TM2NMd1B3ZjN4Y1pvcGVWb3Z3cTBhRUI3WU1MWDdTZUFOVlZ0dHBMcFc1QnhnWVV3N3ItVGxHVUREekdKOWNRNzdob3p) |
| Medscape | FDA Approves First-In-Class Med for Parkinson's Disease | 2026-09-28 12:15 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxQVkJmZVFjYkR2UzVNWF8yRFh2d2xtRDdtNFRrbVlTMGx6OU0wSEpkSHM2R19neWYzWmV5ZTBmUkNFbVRuYXJNR3dzTHZyU2t1X28zZ3hYUGRGV3pzWEFTTHQ2S0RXOHpzQTBTZW9Oa2d1eVdaS254cUlEN2s3X1FpNUpGOHdmQXhFWHN5X2hRcFRkYWlZLXZyYlJoZmd3QQ?oc=5) |
| FOX 8 News | FDA approves ‘breakthrough’ Parkinson’s treatment led by Cleveland Clinic doctor | 2026-09-28 12:15 | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxPbmZKbUkyOV9KTWtOczh2SmlqaFBNZUl3eXQ3SVRJd3QtRzdtS08tWEJvdkJxUkZZVlFhck40bjdWZTVLblNOQkJPT01UQ1hZY1JJZGN0SnVxVmdWLU1VVlpVN2RjeV83WUpwc0tudHl4dWl2T2Q2TlhtaEhtRFJJM2tXMHl2RU4xb0UtYm5HZ0cyZGIwTzZJZ2czUXVtTTVXS1HSAacBQVVfeXFMUHRTRkVwME1ZdlJCZGRpUVZFZFgxYnI5TmRUbFBEOWxiOWFIU2NZSEY4bVdfeXRuSnZYRW9CcWNFNnVxcmwzYnBqbmZrLXhRVDh0ZzR3anduNXJZOUFXMWNnbXpNYWFMNjZpNVgtSU40cDBqNVhZZWtwZC02UmRfUjl6ZnIwOXpUQnl5aXJmVzY4dGVGSERuVndGOTZsOW9SR0t1VFFjLTg?oc=5) |
| Crain's Chicago Business | AbbVie’s $8.7B Cerevel deal pays off with Parkinson’s drug approved for U.S. patients | 2026-09-28 12:15 | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxONHZ5anc2ZDF4SUlqUkFNR0xJampIampVMlNfb2lfSmVwaTg4UEUxVDV4MFlYVEZ2aXotbjBWclZCQ1pOR2tKU29sbzhjTENhTG5INTNDQ3hocFBqVzJpWkxCUGdQdC1kRGRja0hTNGl5UXl5ZkFNbDk2dHBBRGJqWTZQVGN6U2NQQUVEZUdUQ1R3MzJlVFNUVWR1Q0hCQjlobFdTX09EeGRjc2tvUUhCd200dw?oc=5) |
| American Journal of Managed Care | Tavapadon for Parkinson Disease Approved by FDA | 2026-09-28 12:15 | [Source Link](https://news.google.com/rss/articles/CBMifkFVX3lxTE50UnRUdlVIWGUtbWFxek5RQzRIQ2YxOHlsckJQdDRpb2FaZnJyODBsMnhxUjFid3k3TmdxUnJxRW5uNmhMamlabUZ4X2IzWHVoS295ZXFKMDRVOVVfQXJOOUxUN1ItVU12d0ZhckhXWHZ3TDRSR2N3MV8tblh2Zw?oc=5) |
| MedPage Today | Parkinson's Disease Gets New Treatment Approved | 2026-09-28 12:15 | [Source Link](https://news.google.com/rss/articles/CBMicEFVX3lxTE9fMUFabl9rcWtrbVBFR2Iwd3lWLXY0cHRYdFdIVWR5SEVBWjFXWFVhM3duUHJxV1ZaY3ZVdFpsQlM2MV9hTGE0QkhtTG5ucnlUcjdkSFNwTVRrcWxvUzhKQURCSWlKeWRRbVpxSFJIWlA?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-28/abbvie-s-cerevel-buyout-delivers-as-fda-gives-go-ahead-to-1st-in-class-juvmo-in*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*